Coexistent Breast Cancer and Essential Thrombocythemia: How We Addressed the Therapeutic Challenges

Case Reports in Hematology
Karan SeegobinLara Zuberi

Abstract

Essential thrombocythemia (ET) occurring with breast cancer is uncommon; the therapeutic approach varies and poses a challenge. A 65-year-old female presented to us after being diagnosed with hormone positive, HER2-negative infiltrating ductal carcinoma. She had a platelet count of 600 thou/cu mm. Her JAK2 mutation was positive. Bone marrow biopsy showed increased megakaryocytes. She was diagnosed with ET in the setting of breast cancer. She underwent breast conservation surgery after which aspirin was resumed. Anticipating thrombocytopenia during chemotherapy and given the absence of data combining hydroxyurea with standard chemotherapy used for breast cancer, we felt it prudent to delay cytoreductive therapy for her ET until after completion of breast cancer treatment. Her average platelet count during chemotherapy was 480 thou/cu mm with the lowest being 377 thou/cu mm. Her platelet count remained at goal between 300 and 350 thou/cu mm after four months of hydroxyurea.

References

Apr 27, 1995·The New England Journal of Medicine·S CortelazzoT Barbui
Oct 31, 2002·Neoplasia : an International Journal for Oncology Research·Graham J CaineSean T Kehoe
Oct 3, 2007·Blood·Marco RuggeriUNKNOWN Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Chronic Myeloproliferative Diseases Working Party
Aug 30, 2008·Therapeutics and Clinical Risk Management·Jean-Marc A Nabholtz
Sep 9, 2010·Rheumatology·Alastair L HepburnJustin C Mason
Nov 26, 2010·Blood·Philip A BeerAnthony R Green
Dec 14, 2011·Hematology·Francisco Cervantes
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Aug 27, 2016·Blood·Elisa Rumi, Mario Cazzola
May 23, 2017·Therapeutic Advances in Medical Oncology·Javier PuenteJose Angel Arranz

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.